Literature DB >> 26040409

Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.

Masafumi Kashii1, Yohei Matuso2, Tsuyoshi Sugiura2, Takahito Fujimori2, Yukitaka Nagamoto2, Takahiro Makino2, Takashi Kaito2, Kosuke Ebina2, Motoki Iwasaki2, Hideki Yoshikawa2.   

Abstract

Sclerostin and dickkopf-1(DKK1) are Wnt/β-catenin signal antagonists that play an important role in bone formation. Ossification of the posterior longitudinal ligament (OPLL) of the spine is characterized by pathological ectopic ossification of the posterior longitudinal ligament and ankylosing spinal hyperostosis. The aims of this study were to evaluate serum sclerostin and DKK1 levels in persons with OPLL and to identify its relationship with bone metabolism and bone mass in persons with OPLL. This was a case-control study, and 78 patients with OPLL were compared with 39 age- and sex-matched volunteers without OPLL. We analyzed the relationship with calciotropic hormones, bone turnover markers, OPLL localization, number of ossified vertebrae, and bone mineral density of total hip (TH-BMD). Serum sclerostin levels in men with OPLL were significantly higher than in men in the control group (control group: mean = 45.3 pmol/L; OPLL group: mean = 75.7 pmol/L; P = 0.002). Age and sclerostin levels were positively correlated in men with OPLL (r = 0.43; P = 0.002). Serum sclerostin levels in men with OPLL had a positive correlation with TH-BMD Z-score (r = 0.511; P = 0.011, n = 30). There was a strong negative correlation between serum sclerostin levels and serum DKK1 levels in men with OPLL (r = -0.506; P < 0.001). Bone and mineral metabolism in OPLL differs between men and women. In men with OPLL, systemic secretion of sclerostin increases with advancing age and with higher bone mass. These two Wnt/β-catenin signal antagonists have the opposite effect in persons with OPLL, and higher serum sclerostin levels are counterbalanced by underproduction of DKK1.

Entities:  

Keywords:  Dickkpf-1; Diffuse idiopathic spinal hyperostosis; Ossification of posterior longitudinal ligament; Sclerostin; Wnt/β catenin signal

Mesh:

Substances:

Year:  2015        PMID: 26040409     DOI: 10.1007/s00774-015-0671-5

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  37 in total

1.  Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.

Authors:  Frederic Morvan; Kim Boulukos; Philippe Clément-Lacroix; Sergio Roman Roman; Isabelle Suc-Royer; Béatrice Vayssière; Patrick Ammann; Patrick Martin; Sonia Pinho; Philippe Pognonec; Patrick Mollat; Christof Niehrs; Roland Baron; Georges Rawadi
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

2.  Bone mineral density in patients with ossification of the posterior longitudinal ligament in the cervical spine.

Authors:  T Yamauchi; E Taketomi; S Matsunaga; T Sakou
Journal:  J Bone Miner Metab       Date:  1999       Impact factor: 2.626

3.  Ossification of the posterior longitudinal ligament of the spine.

Authors:  N Tsuyama
Journal:  Clin Orthop Relat Res       Date:  1984-04       Impact factor: 4.176

4.  Significance of bone formation markers in patients with ossification of the posterior longitudinal ligament of the spine.

Authors:  Kazuhito Sugimori; Yoshiharu Kawaguchi; Kazuo Ohmori; Masahiko Kanamori; Hirokazu Ishihara; Tomoatsu Kimura
Journal:  Spine (Phila Pa 1976)       Date:  2003-02-15       Impact factor: 3.468

5.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

Review 6.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

7.  [Affinity of estrogen binding in the cultured spinal ligament cells: an in vitro study using cells from spinal ligament ossification patients].

Authors:  A Wada
Journal:  Nihon Seikeigeka Gakkai Zasshi       Date:  1995-07

8.  The extent of ossification of posterior longitudinal ligament of the spine associated with nucleotide pyrophosphatase gene and leptin receptor gene polymorphisms.

Authors:  Masamichi Tahara; Atsuomi Aiba; Masashi Yamazaki; Yoshikazu Ikeda; Sumio Goto; Hideshige Moriya; Akihiko Okawa
Journal:  Spine (Phila Pa 1976)       Date:  2005-04-15       Impact factor: 3.468

9.  Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

Authors:  Ulrike I Mödder; Kelley A Hoey; Shreyasee Amin; Louise K McCready; Sara J Achenbach; B Lawrence Riggs; L Joseph Melton; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2011-02       Impact factor: 6.741

10.  Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.

Authors:  Rutger L van Bezooijen; Bernard A J Roelen; Annemieke Visser; Lianne van der Wee-Pals; Edwin de Wilt; Marcel Karperien; Herman Hamersma; Socrates E Papapoulos; Peter ten Dijke; Clemens W G M Löwik
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

View more
  12 in total

Review 1.  Biomarker Research Approach to the Pathogenesis of Ossification of the Spinal Ligament: A Review.

Authors:  Yoshiharu Kawaguchi
Journal:  Spine Surg Relat Res       Date:  2022-04-12

2.  Identification and Functional Characterization of RSPO2 as a Susceptibility Gene for Ossification of the Posterior Longitudinal Ligament of the Spine.

Authors:  Masahiro Nakajima; Ikuyo Kou; Hirofumi Ohashi; Shiro Ikegawa
Journal:  Am J Hum Genet       Date:  2016-06-30       Impact factor: 11.025

3.  Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL.

Authors:  Chi-Chien Niu; Song-Shu Lin; Li-Jen Yuan; Lih-Huei Chen; Chuen-Yung Yang; An-Ni Chung; Meng-Ling Lu; Tsung-Ting Tsai; Po-Liang Lai; Wen-Jer Chen
Journal:  BMC Musculoskelet Disord       Date:  2017-02-02       Impact factor: 2.362

4.  Increase of the Serum FGF-23 in Ossification of the Posterior Longitudinal Ligament.

Authors:  Yoshiharu Kawaguchi; Isao Kitajima; Masato Nakano; Taketoshi Yasuda; Shoji Seki; Kayo Suzuki; Yasuhito Yahara; Hiroto Makino; Yasuhiro Ujihara; Tomohiro Ueno; Tomoatsu Kimura
Journal:  Global Spine J       Date:  2018-09-27

Review 5.  Biomarkers of Ossification of the Spinal Ligament.

Authors:  Yoshiharu Kawaguchi
Journal:  Global Spine J       Date:  2018-07-26

6.  Concomitant Fahr's syndrome and thoracic ossification of the posterior longitudinal ligament caused by idiopathic hypoparathyroidism - case report.

Authors:  Ikchan Jeon; Kyu Hyang Cho; Sang Woo Kim
Journal:  BMC Musculoskelet Disord       Date:  2019-08-07       Impact factor: 2.362

7.  Factors associated with bone metabolism in patients with cervical ossification of the posterior longitudinal ligament accompanied with diffuse idiopathic skeletal hyperostosis.

Authors:  Shinji Horie; Yasunobu Sawaji; Kenji Endo; Hidekazu Suzuki; Yuji Matsuoka; Hirosuke Nishimura; Takeshi Seki; Kengo Yamamoto
Journal:  SICOT J       Date:  2018-03-16

Review 8.  The Pathogenesis of Ossification of the Posterior Longitudinal Ligament.

Authors:  Liang Yan; Rui Gao; Yang Liu; Baorong He; Shemin Lv; Dingjun Hao
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745

9.  Autophagy in spinal ligament fibroblasts: evidence and possible implications for ossification of the posterior longitudinal ligament.

Authors:  Yuehua Yang; Zunwen Lin; Jiangwei Chen; Sheng Ding; Weiwei Mao; Sheng Shi; Biru Liang
Journal:  J Orthop Surg Res       Date:  2020-10-22       Impact factor: 2.359

10.  Promoting effect of long non-coding RNA SNHG1 on osteogenic differentiation of fibroblastic cells from the posterior longitudinal ligament by the microRNA-320b/IFNGR1 network.

Authors:  Yuqiang Wang; Huixia Niu; Yilin Liu; Hao Yang; Min Zhang; Limin Wang
Journal:  Cell Cycle       Date:  2020-10-05       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.